Open AccessComparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
Author(s) -
Yanming Zeng,
Xiaolei Xu,
Xiaoqing He,
ShengQuan Tang,
Yao Li,
Yin-Qiu Huang,
Vijay Harypursat,
Yao-Kai Chen
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000790
Subject(s) - medicine , ribavirin , lopinavir , ritonavir , virology , coronavirus , alpha interferon , pneumonia , viral pneumonia , interferon , immunology , disease , viral load , virus , covid-19 , infectious disease (medical specialty) , hepatitis c virus , antiretroviral therapy